Cite

HARVARD Citation

    Buchbinder, E. et al. (2016). A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma. Journal for immunotherapy of cancer. 4 (1), p. . [Online]. 
  
Back to record